- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT07747701
Ultra-early Identification of Futile Recanalization After Reperfusion Therapy in Acute Ischemic Stroke Based on Cerebral Autoregulation Monitoring (FACTOR)
Ultra-early Identification of Futile Recanalization After Reperfusion Therapy in Acute Ischemic Stroke Based on Cerebral Autoregulation Monitoring: a Multicenter, Prospective, Interventional Study
This multicenter, prospective, and interventional diagnostic accuracy study enrolls patients undergoing thrombectomy with intraoperative cerebral autoregulation monitoring and follows them up at predefined time points up to 90 days post-enrollment.This study aims to evaluate a monitoring system based on cerebral autoregulation function and explore its predictive value for adverse neurological outcomes at the ultra-early stage following mechanical thrombectomy.
연구 개요
상태
연구 유형
등록 (추정된)
단계
- 해당 없음
연락처 및 위치
연구 연락처
- 이름: Shen Li
- 전화번호: 010-63925616
- 이메일: lishen@mail.ccmu.edu.cn
연구 연락처 백업
- 이름: Simeng Wang
- 전화번호: 010-63925615
- 이메일: wsm990419@163.com
연구 장소
-
-
-
Beijing, 중국
- 모병
- Beijing Shijitan Hospital, Capital Medical University
-
수석 연구원:
- Shen Li
-
연락하다:
- Shen Li
- 전화번호: 010-63925616
- 이메일: lishen@mail.ccmu.edu.cn
-
Dalian, 중국
- 모병
- Central Hospital of Dalian University of Technology (Dalian Municipal Central Hospital)
-
연락하다:
- Xiaoyan Lan
- 전화번호: +86 15840985380
- 이메일: jinnerlan@hotmail.com
-
수석 연구원:
- Xiaoyan Lan
-
Heilongjiang, 중국
- 모병
- The First Affiliated Hospital of Harbin Medical University
-
수석 연구원:
- Guang Zhang
-
연락하다:
- Guang Zhang
- 전화번호: +86 13945085063
- 이메일: Zhangguang@hrbmu.edu.cn
-
Shandong, 중국
- 모병
- Weifang People's Hospital Affiliated to Weifang Medical University
-
수석 연구원:
- Weili Li
-
연락하다:
- Weili Li
- 전화번호: +86 15169697295
- 이메일: liweili0536@163.com
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- Age ≥ 18
- Diagnosis of acute ischemic stroke caused by anterior circulation large vessel occlusion (intracranial internal carotid artery or M1 segment of the middle cerebral artery).
- National Institutes of Health Stroke Scale (NIHSS) score ≥ 6 at presentation.
- Pre-stroke modified Rankin Scale (mRS) score ≤ 1.
- Symptom onset ≤ 24 hours.
- For patients with symptom onset within 6 hours: ASPECTS ≥ 6; for patients with symptom onset between 6 and 24 hours: age ≤ 80 years and ASPECTS ≥ 3.
- Underwent mechanical thrombectomy and achieved successful recanalization (mTICI 2b-3).
- Patient or legally authorized representative provides written informed consent.
Exclusion Criteria:
- Pre-procedural baseline imaging showing significant intracranial hemorrhagic transformation, intracranial arterial dissection, large chronic cerebral infarction, or intracranial metastasis from malignant tumors.
- Any degree of stenosis, plaque, dissection, severe tortuosity, or imaging evidence of unstable/vulnerable plaque in the target-side or bilateral common carotid artery or the origin of the internal carotid artery.
- Known history of carotid sinus hypersensitivity syndrome, severe autonomic dysfunction, sick sinus syndrome, high-grade atrioventricular conduction block, or other malignant arrhythmias.
- Refractory malignant hypertensive crisis (systolic blood pressure persistently ≥ 200 mmHg despite standardized intravenous antihypertensive therapy, or hemodynamic instability with shock).
- Known severe allergy to contrast agents or anesthetic drugs, or contraindications to antiplatelet/anticoagulation therapy.
- Severe systemic active infection, multiple organ failure, or expected survival < 6 months.
- Severe hepatic or renal dysfunction (ALT/AST > 3× upper limit of normal; estimated glomerular filtration rate < 30 mL/min) or severe coagulation disorders (platelet count < 40 × 10⁹/L, APTT > 50 s, INR > 3.0).
- Blood glucose < 2.7 mmol/L or > 22.2 mmol/L.
- Heart failure with NYHA class > II, or persistent systolic blood pressure < 100 mmHg.
- Central nervous system infection or intracranial tumor.
- Unstable vital signs.
- Severe alcohol dependence or drug dependence.
- Cognitive impairment or psychiatric disorders that may affect follow-up assessments.
- Pregnant or breastfeeding women.
- Participation in another clinical drug or device study within the past 30 days.
- Local skin damage or other conditions preventing proper placement of monitoring electrodes.
- Severe agitation or other conditions that interfere with data acquisition.
- Any other condition judged by investigators to potentially affect study results.
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 특수 증상
- 할당: 해당 없음
- 중재 모델: 단일 그룹 할당
- 마스킹: 없음(오픈 라벨)
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
실험적: Cerebral Autoregulation Monitoring After Mechanical Thrombectomy
Participants with acute intracranial large vessel occlusion in the anterior circulation who achieve successful recanalization (mTICI 2b-3) after mechanical thrombectomy will undergo bedside cerebral autoregulation monitoring. Monitoring includes continuous near-infrared spectroscopy (NIRS) to record cerebral oxygen saturation and continuous noninvasive or invasive blood pressure measurement for 25-30 minutes immediately after recanalization. A carotid compression test is performed to dynamically assess cerebral autoregulation. |
Bedside multimodal cerebral autoregulation monitoring performed immediately after successful mechanical thrombectomy (mTICI 2b-3). Monitoring includes continuous near-infrared spectroscopy (NIRS) to record cerebral oxygen saturation and continuous noninvasive or invasive arterial blood pressure measurement for 25-30 minutes. Cerebral oxygenation index (COx) is calculated as a moving Pearson correlation coefficient between mean arterial pressure and cerebral oxygen saturation over 30 consecutive 10-second epochs (300 seconds). COx ≥ 0.3 indicates impaired cerebral autoregulation, while COx < 0.3 indicates preserved autoregulation. Changes in cerebral oxygen saturation before and after carotid compression are also used to assess autoregulatory. A carotid compression test is performed by compressing the common carotid artery at the lower one-third of the neck (avoiding the carotid sinus) against the transverse process of C6 until pulsation disappears for 5-10 seconds, followed by release. If the brain oxygen saturation has increased compared to before the test, it indicates that the brain's automatic blood flow regulation function is intact; conversely, if it has decreased, it is regarded as a damaged automatic blood flow regulation function of the brain. |
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Distribution of Modified Rankin scale
기간: 90±7days
|
the distribution of Modified Rankin scale (mRS) [ranging from 0 (normal) to 6 (death)] |
90±7days
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Early neurological improvement
기간: 24±12 hours
|
Early neurological improvement is defined as a reduction of ≥8 on the National Institutes of Health Stroke Scale [ranging from 0 to 42 points, with higher numbers indicating greater severity] or National nstitutes of Health Stroke Scale zero to one 24 hours after thrombectomy. |
24±12 hours
|
공동 작업자 및 조사자
수사관
- 수석 연구원: Shen Li, Beijing Shijitan Hospital, Capital Medical University
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (추정된)
연구 완료 (추정된)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
기타 연구 ID 번호
- FACTOR
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
IPD 계획 설명
The deidentified individual participant data underlying this article will not be publicly available. However, the data may be made available to researchers upon reasonable request to the corresponding author, subject to approval by the institutional review board and execution of a data access agreement.
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .